RESUMO
Currently available drugs for treatment of glioblastoma, the most aggressive brain tumor, remain inefficient, thus a plethora of natural compounds have already been shown to have antimalignant effects. However, these have not been tested for their impact on tumor cells in their microenvironment-simulated cell models, e.g., mesenchymal stem cells in coculture with glioblastoma cell U87 (GB). Mesenchymal stem cells (MSC) chemotactically infiltrate the glioblastoma microenvironment. Our previous studies have shown that bone-marrow derived MSCs impair U87 growth and invasion via paracrine and cell-cell contact-mediated cross-talk. Here, we report on a plant-derived protein, obtained from Crataeva tapia tree Bark Lectin (CrataBL), having protease inhibitory/lectin activities, and demonstrate its effects on glioblastoma cells U87 alone and their cocultures with MSCs. CrataBL inhibited U87 cell invasion and adhesion. Using a simplified model of the stromal microenvironment, i.e., GB/MSC direct cocultures, we demonstrated that CrataBL, when added in increased concentrations, caused cell cycle arrest and decreased cocultured cells' viability and proliferation, but not invasion. The cocultured cells' phenotypes were affected by CrataBL via a variety of secreted immunomodulatory cytokines, i.e., G-CSF, GM-CSF, IL-6, IL-8, and VEGF. We hypothesize that CrataBL plays a role by boosting the modulatory effects of MSCs on these glioblastoma cell lines and thus the effects of this and other natural lectins and/or inhibitors would certainly be different in the tumor microenvironment compared to tumor cells alone. We have provided clear evidence that it makes much more sense testing these potential therapeutic adjuvants in cocultures, mimicking heterogeneous tumor-stroma interactions with cancer cells in vivo. As such, CrataBL is suggested as a new candidate to approach adjuvant treatment of this deadly tumor.
Assuntos
Capparaceae/química , Células-Tronco Mesenquimais/efeitos dos fármacos , Casca de Planta/química , Extratos Vegetais/farmacologia , Lectinas de Plantas/farmacologia , Inibidores de Proteases/farmacologia , Adesão Celular/efeitos dos fármacos , Ciclo Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Técnicas de Cocultura , Citocinas/biossíntese , Glioblastoma/metabolismo , Humanos , Células-Tronco Mesenquimais/metabolismo , Metaloproteases/antagonistas & inibidores , Óxido Nítrico/biossíntese , Extratos Vegetais/química , Lectinas de Plantas/química , Inibidores de Proteases/químicaRESUMO
Palythoa caribaeorum is a very common colonial zoanthid in the coastal reefs of Brazil. It is known for its massive production of mucus, which is traditionally used in folk medicine by fishermen in northeastern Brazil. This study identified biologically active compounds in P. caribaerum mucus. Crude mucus was collected during low tides by the manual scraping of colonies; samples were maintained in an ice bath, homogenized, and centrifuged at 16,000â¯g for 1â¯hâ¯at 4⯰C; the supernatant (mucus) was kept at -80⯰C until use. The enzymatic (proteolytic and phospholipase A2), inhibitory (metallo, cysteine and serine proteases), and hemagglutinating (human erythrocyte) activities were determined. The results showed high levels of cysteine and metallo proteases, intermediate levels of phosholipase A2, low levels of trypsin, and no elastase and chymotrypsin like activities. The mucus showed potent inhibitory activity on snake venom metalloproteases and cysteine proteinase papain. In addition, it showed agglutinating activity towards O+, B+, and A+ erythrocyte types. The hemostatic results showed that the mucus prolongs the aPTT and PT, and strongly inhibited platelet aggregation induced by arachidonic acid, collagen, epinephrine, ADP, and thrombin. The antimicrobial activity was tested on 15 strains of bacteria and fungi through the radial diffusion assay in agar, and no activity was observed. Compounds in P. caribaeorum mucus were analyzed for the first time in this study, and our results show potential pharmacological activities in these compounds, which are relevant for use in physiopathological investigations. However, the demonstration of these activities indicates caution in the use of crude mucus in folk medicine. Furthermore, the present or absent activities identified in this mucus suggest that the studied P. caribaeorum colonies were in thermal stress conditions at the time of sample collection; these conditions may precede the bleaching process in zoanthids. Hence, the use of mucus as an indicator of this process should be evaluated in the future.
Assuntos
Antozoários/química , Muco/química , Proteínas/farmacologia , Animais , Anti-Infecciosos , Produtos Biológicos , Brasil , Venenos de Crotalídeos/antagonistas & inibidores , Eritrócitos , Hemaglutinação , Humanos , Medicina Tradicional , Metaloproteases/antagonistas & inibidoresRESUMO
Bioactive peptide research has experienced considerable therapeutic interest owing to varied physiological functions, efficacy in excretion, and tolerability of peptides. Colostrum is a rich natural source of bioactive peptides with many properties elucidated such as anti-thrombotic, anti-hypertensive, opioid, immunomodulatory, etc. In this study, a variant peptide derived from ß-lactoglobulin from buffalo colostrum was evaluated for the anti-ophidian property by targeting snake venom metalloproteinases. These are responsible for rapid local tissue damages that develop after snakebite such as edema, hemorrhage, myonecrosis, and extracellular matrix degradation. The peptide identified by LC-MS/MS effectively neutralized hemorrhagic activity of the Echis carinatus venom in a dose-dependent manner. Histological examinations revealed that the peptide mitigated basement membrane degradation and accumulation of inflammatory leucocytes at the venom-injected site. Inhibition of proteolytic activity was evidenced in both casein and gelatin zymograms. Also, inhibition of fibrinolytic and fibrinogenolytic activities was seen. The UV-visible spectral study implicated Zn2+ chelation, which was further confirmed by molecular docking and dynamic studies by assessing molecular interactions, thus implicating the probable mechanism for inhibition of venom-induced proteolytic and hemorrhagic activities. The present investigation establishes newer vista for the BLG-col peptide with anti-ophidian efficacy as a promising candidate for therapeutic interventions.
Assuntos
Búfalos , Colostro/química , Lactoglobulinas/química , Metaloproteases/antagonistas & inibidores , Fragmentos de Peptídeos/farmacologia , Venenos de Víboras/enzimologia , Viperidae , Sequência de Aminoácidos , Animais , Caseínas/metabolismo , Simulação por Computador , Edema/tratamento farmacológico , Fibrina/metabolismo , Fibrinogênio/metabolismo , Hemorragia/induzido quimicamente , Hemorragia/tratamento farmacológico , Hidrólise , Metaloproteases/química , Metaloproteases/metabolismo , Camundongos , Simulação de Acoplamento Molecular , Simulação de Dinâmica Molecular , Oligopeptídeos/química , Oligopeptídeos/metabolismo , Oligopeptídeos/farmacologia , Oligopeptídeos/uso terapêutico , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/metabolismo , Fragmentos de Peptídeos/uso terapêutico , Inibidores de Proteases/química , Inibidores de Proteases/metabolismo , Inibidores de Proteases/farmacologia , Inibidores de Proteases/uso terapêutico , Conformação Proteica , Proteólise/efeitos dos fármacos , Pele/efeitos dos fármacosRESUMO
Previously, we established delayed jellyfish envenomation syndrome (DJES) models and proposed that the hemorrhagic toxins in jellyfish tentacle extracts (TE) play a significant role in the liver and kidney injuries of the experimental model. Further, we also demonstrated that metalloproteinases are the central toxic components of the jellyfish Cyanea capillata (C. capillata), which may be responsible for the hemorrhagic effects. Thus, metalloproteinase inhibitors appear to be a promising therapeutic alternative for the treatment of hemorrhagic injuries in DJES. In this study, we examined the metalloproteinase activity of TE from the jellyfish C. capillata using zymography analyses. Our results confirmed that TE possessed a metalloproteinase activity, which was also sensitive to heat. Then, we tested the effect of metalloproteinase inhibitor batimastat (BB-94) on TE-induced hemorrhagic injuries in DJES models. Firstly, using SR-based X-ray microangiography, we found that BB-94 significantly improved TE-induced hepatic and renal microvasculature alterations in DJES mouse model. Secondly, under synchrotron radiation micro-computed tomography (SR-µCT), we also confirmed that BB-94 reduced TE-induced hepatic and renal microvasculature changes in DJES rat model. In addition, being consistent with the imaging results, histopathological and terminal deoxynucleotidyl transferase-mediated UTP end labeling (TUNEL)-like staining observations also clearly corroborated this hypothesis, as BB-94 was highly effective in neutralizing TE-induced extensive hemorrhage and necrosis in DJES rat model. Although it may require further clinical studies in the near future, the current study opens up the possibilities for the use of the metalloproteinase inhibitor, BB-94, in the treatment of multiple organ hemorrhagic injuries in DJES.
Assuntos
Mordeduras e Picadas/tratamento farmacológico , Venenos de Cnidários/toxicidade , Hemorragia/prevenção & controle , Fenilalanina/análogos & derivados , Substâncias Protetoras/uso terapêutico , Cifozoários , Tiofenos/uso terapêutico , Angiografia , Animais , Marcação In Situ das Extremidades Cortadas , Rim/efeitos dos fármacos , Rim/patologia , Fígado/efeitos dos fármacos , Fígado/patologia , Masculino , Metaloproteases/antagonistas & inibidores , Metaloproteases/química , Metaloproteases/toxicidade , Camundongos , Necrose/prevenção & controle , Fenilalanina/uso terapêutico , Ratos , Ratos Sprague-Dawley , Síndrome , Microtomografia por Raio-XRESUMO
BACKGROUND: Citrus peels are consumed in the form of infusions, candy or wine, based on their well-documented nutritional and medicinal properties. This study sought to investigate the effect of some citrus peels' [grapefruit (Citrus paradisii), orange (Citrus sinensis) and shaddock (Citrus maxima)] extracts on matrix metalloproteinase (MMP) and proteasome activities in primary human colonic tumor (Caco-2) and the metastatic cell lines (LoVo and LoVo/ADR) in a bid to explain the possible mechanism by which the peels could manage/prevent colon cancer. METHODS: The inhibition of MMP and proteasome activities in the cells by the peel extracts, as well as the identification of phenolic compounds using high-performance liquid chromatography with diode-array detection (HPLC-DAD), was determined. RESULTS: Orange peel extracts had the strongest inhibition of MMP in Caco-2 and LoVo cells, while shaddock had the least. Shaddock peel extracts also had the least MMP inhibition in LoVo/ADR lysates. Grapefruit had the least proteasome inhibition in Caco-2 and LoVo lysates, while there was no significant (p>0.05) difference in the proteasome inhibition of the peel extracts in LoVo/ADR lysates. The extracts inhibited proteasome activity in extract-treated cells, and HPLC fingerprinting of the extracts revealed the presence of some phenolic compounds such as quercetin, caffeic acid, kaempferol, catechin and naringin. CONCLUSIONS: The inhibition of MMP and proteasome activities in colon cancer cell lines suggests the potential use of citrus peels as functional food in the management and/or prevention of colon cancer.
Assuntos
Citrus/química , Neoplasias do Colo/tratamento farmacológico , Frutas/química , Metaloproteases/antagonistas & inibidores , Extratos Vegetais/farmacologia , Complexo de Endopeptidases do Proteassoma/efeitos dos fármacos , Células CACO-2 , Linhagem Celular Tumoral , Neoplasias do Colo/metabolismo , Humanos , Fenóis/química , Fenóis/farmacologia , Extratos Vegetais/químicaRESUMO
Viperbites undeniably cause local manifestations such as hemorrhage and myotoxicity involving substantial degradation of extracellular matrix (ECM) at the site of envenomation and lead to progressive tissue damage and necrosis. The principle toxin responsible is attributed to snake venom metalloproteases (SVMPs). Treatment of such progressive tissue damage induced by SVMPs has become a challenging task for researchers and medical practitioners who are in quest of SVMPs inhibitors. In this study, we have evaluated the inhibitory potential of three specific zinc (Zn(2+)) chelating agents; N,N,N',N'-tetrakis (2-pyridylmethyl) ethane-1,2-diamine (TPEN), diethylene triamine pentaacetic acid (DTPA), tetraethyl thiuram disulfide (TTD) on Echis carinatus venom (ECV) induced hemorrhage and myotoxicity. Amongst them, TPEN has high affinity for Zn(2+) and revealed potent inhibition of ECV metalloproteases (ECVMPs) in vitro (IC50: 6.7 µM) compared to DTPA and TTD. The specificity of TPEN towards Zn(2+) was confirmed by spectral and docking studies. Further, TPEN, DTPA, and TTD completely blocked the hemorrhagic and myotoxic activities of ECV in a dose dependent manner upon co-injection; whereas, only TPEN successfully neutralized hemorrhage and myotoxicity following independent injection. Histological examinations revealed that TPEN effectively prevents degradation of dermis and basement membrane surrounding the blood vessels in mouse skin sections. TPEN also prevents muscle necrosis and accumulation of inflammatory cells at the site of ECV injections. In conclusion, a high degree of structural and functional homology between mammalian MMPs and SVMPs suggests that specific Zn(2+) chelators currently in clinical practice could be potent first aid therapeutic agents in snakebite management, particularly for local tissue damage.
Assuntos
Quelantes/farmacologia , Metaloproteases/antagonistas & inibidores , Venenos de Víboras/química , Venenos de Víboras/metabolismo , Viperidae/metabolismo , Zinco/química , Animais , Antivenenos/química , Quelantes/análise , Quelantes/metabolismo , Dissulfiram/metabolismo , Dissulfiram/farmacologia , Relação Dose-Resposta a Droga , Etilenodiaminas/metabolismo , Etilenodiaminas/farmacologia , Metaloproteases/toxicidade , Camundongos , Ácido Pentético/metabolismo , Ácido Pentético/farmacologia , Espectrofotometria Ultravioleta , Venenos de Víboras/toxicidadeRESUMO
ETHNOPHARMACOLOGICAL RELEVANCE: The plant Renealmia alpinia has been used in folk medicine to treat snakebites in the northwest region of Colombia. In addition, it has been shown to neutralize edema-forming, hemorrhagic, lethal, and defibrin(ogen)ating activities of Bothrops asper venom. In this work, extracts of Renealmia alpinia obtained by micropropagation (in vitro) and from specimens collected in the wild were tested and compared in their capacity to inhibit enzymatic and toxic activities of a snake venom metalloproteinase isolated from Bothrops atrox (Batx-I) venom and a serine proteinase (Cdc SII) from Crotalus durissus cumanensis venom. MATERIALS AND METHODS: We have investigated the inhibition capacity of Renealmia alpinia extracts on enzymatic and toxic actions of isolated toxins, a metalloproteinase and a serine proteinase. The protocols investigated included inhibition of proteolytic activity on azocasein, inhibition of proteolytic activity on fibrinogen, inhibition of pro-coagulant activity, inhibition of hemorrhagic activity and inhibition of edema-forming activity. RESULTS: Colorimetric assays detected the presence of terpenoids, flavonoids, tannins and coumarins in Renealmia alpinia extracts. Renealmia alpinia extracts inhibited the enzymatic, hemorrhagic and fibrinogenolytic activities of Batx-I. Extracts also inhibited coagulant, defibrin(ogen)ating and edema-forming activities of Cdc SII. Results highlight that Renealmia alpinia in vitro extract displayed comparable inhibitory capacity on venom proteinases that Renealmia alpinia wild extract. No alteration was observed in the electrophoretic pattern of venom proteinases after incubation with Renealmia alpinia extracts, thus excluding proteolytic degradation or protein denaturation/precipitation as a mechanism of inhibition. CONCLUSIONS: Our results showed that Renealmia alpinia wild and in vitro extracts contain compounds that neutralize metallo- and serine proteinases present in snake venoms. The mechanism of inhibition is not related to proteolytic degradation of the enzymes nor protein aggregation, but is likely to depend on molecular interactions of secondary metabolites in the plant with these venom proteinases.
Assuntos
Venenos de Crotalídeos/antagonistas & inibidores , Metaloproteases/antagonistas & inibidores , Extratos Vegetais/farmacologia , Inibidores de Serina Proteinase/farmacologia , Zingiberaceae , Animais , Venenos de Crotalídeos/farmacologia , Edema/prevenção & controle , Fibrinogênio/antagonistas & inibidores , Hemorragia/prevenção & controle , Metaloproteases/farmacologia , Camundongos , Serina Proteases/metabolismoRESUMO
Snake venom metalloproteinases (SVMPs) participate in a number of important biological, physiological and pathophysiological processes and are primarily responsible for the local tissue damage characteristic of viperid snake envenomations. The use of medicinal plant extracts as antidotes against animal venoms is an old practice, especially against snake envenomations. Such plants are sources of many pharmacologically active compounds and have been shown to antagonize the effects of some venoms and toxins. The present study explores the activity of triacontyl p-coumarate (PCT), an active compound isolated from root bark of Bombacopsis glabra vegetal extract (Bg), against harmful effects of Bothropoides pauloensis snake venom and isolated toxins (SVMPs or phospholipase A(2)). Before inhibition assays, Bg or PCT was incubated with venom or toxins at ratios of 1:1 and 1:5 (w/w; venom or isolated toxins/PCT) for 30 min at 37°C. Treatment conditions were also assayed to simulate snakebite with PCT inoculated at either the same venom or toxin site. PCT neutralized fibrinogenolytic activity and plasmatic fibrinogen depletion induced by B. pauloensis venom or isolated toxin. PCT also efficiently inhibited the hemorrhagic (3MDH - minimum hemorrhagic dose injected i.d into mice) and myotoxic activities induced by Jararhagin, a metalloproteinase from B. jararaca at 1:5 ratio (toxin: inhibitor, w/w) when it was previously incubated with PCT and injected into mice or when PCT was administered after toxin injection. Docking simulations using data on a metalloproteinase (Neuwiedase) structure suggest that the binding between the protein and the inhibitor occurs mainly in the active site region causing blockade of the enzymatic reaction by displacement of catalytic water. Steric hindrance may also play a role in the mechanism since the PCT hydrophobic tail was found to interact with the loop associated with substrate anchorage. Thus, PCT may provide a alternative to complement ophidian envenomation treatments.
Assuntos
Ácidos Cumáricos/química , Ácidos Cumáricos/farmacologia , Metaloproteases/antagonistas & inibidores , Metaloproteases/metabolismo , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Venenos de Serpentes/enzimologia , AnimaisRESUMO
Angiotensin-I converting enzyme (ACE) is a zinc dependent peptidase with a major role in regulating vasoactive peptide metabolism. ACE, a transmembrane protein, undergoes proteolysis, or shedding, by an as yet unidentified proteinase to release a catalytically active soluble form of the enzyme. Physiologically, soluble ACE in plasma is derived primarily from endothelial cells. We demonstrate that ACE shedding from confluent endothelial cells is increased in response to bacterial lipopolysaccharide, but not phorbol esters. Characterisation of lipopolysaccharide stimulated shedding showed that there is a lag phase before soluble ACE can be detected which is sensitive to inhibitors of translation, NF-κB, TNFα and TNFR-I/II. The shedding phase is less sensitive to these inhibitors, but is ablated by BB-94, a Matrix Metalloproteinase (MMP)/A Disintegrin and Metalloproteinase (ADAM) inhibitor. Tissue Inhibitor of Metalloproteinase (TIMP) profiling suggested a requirement for ADAM9 in lipopolysaccharide induced ACE shedding, which was confirmed by depletion with siRNA. Transient transfection of ADAM9 and ACE cDNAs into HEK293 cells demonstrated that ADAM9 requires both membrane anchorage and its catalytic domain to shed ACE.
Assuntos
Proteínas ADAM/metabolismo , Células Endoteliais/enzimologia , Lipopolissacarídeos/metabolismo , Proteínas de Membrana/metabolismo , Proteínas ADAM/genética , Domínio Catalítico , Membrana Celular/enzimologia , DNA Complementar , Desintegrinas/antagonistas & inibidores , Células Endoteliais/efeitos dos fármacos , Células HEK293 , Humanos , Lipopolissacarídeos/farmacologia , Inibidores de Metaloproteinases de Matriz , Proteínas de Membrana/genética , Metaloproteases/antagonistas & inibidores , NF-kappa B/metabolismo , Peptidil Dipeptidase A , Fenilalanina/análogos & derivados , Fenilalanina/farmacologia , Ésteres de Forbol/metabolismo , Ésteres de Forbol/farmacologia , Inibidores de Proteases/farmacologia , Receptores Tipo I de Fatores de Necrose Tumoral/metabolismo , Receptores Tipo II do Fator de Necrose Tumoral/metabolismo , Tiofenos/farmacologia , Fator de Necrose Tumoral alfa/metabolismoRESUMO
AIM: To evaluate the protective role of AE-941, a matrix metalloproteinase (MMP) inhibitor, on ulcerative colitis (UC) in rats. METHODS: Sprague Dawley (SD) rats were randomly divided into three groups: a control group, an AE-941 treatment group, and an UC model group. Rats were sacrificed on days 7, 21, or 56 following administration of treatment by enema and the disease activity index (DAI), colonic mucosa damage index (CMDI) and colonic expression of MMP-2 and MMP-9 were assessed. RESULTS: DAI and CDMI scores in the UC model group increased significantly compared to the control group at all timepoints (P < 0.001), and also increased significantly at the 21- and 56-d timepoints compared to the AE-941-treated group (DAI: 21- and 56-d = 2.09 ± 0.25, 1.52 ± 0.30 vs 1.55 ± 0.28, 0.59 ± 0.19, respectively, P = 0.040 and 0.007, CMDI: 21- and 56-d = 3.03 ± 0.42, 1.60 ± 0.35 vs 2.08 ± 0.46, 0.86 ± 0.37, respectively, P = 0.040 and 0.005). Furthermore, the colonic expression of MMP-2 and MMP-9 in the UC model group increased significantly compared to the control group (P < 0.001), and also increased compared to the AE-941-treated group on the 21- and 56-d timepoints (MMP-2: 21- and 56-d = 0.6048 ± 0.0522, 0.4163 ± 0.0330 vs 0.3983 ± 0.0218, 0.1093 ± 0.0072, respectively, P = 0.010; MMP-9: 21- and 56-d = 0.6873 ± 0.0472, 0.4328 ± 0.0257 vs 0.5179 ± 0.0305, 0.2673 ± 0.0210, respectively, P = 0.010 and 0.040). CONCLUSION: Expression of MMP-2 and MMP-9 increased significantly in rats with UC. AE-941 can reduce colonic mucosal damage by downregulating the expression of MMP-2 and MMP-9.
Assuntos
Colite Ulcerativa/tratamento farmacológico , Inibidores Enzimáticos/farmacologia , Metaloproteases/antagonistas & inibidores , Extratos de Tecidos/farmacologia , Animais , Colite Ulcerativa/prevenção & controle , Colo/efeitos dos fármacos , Matriz Extracelular/metabolismo , Imuno-Histoquímica , Masculino , Metaloproteinase 2 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-DawleyRESUMO
Snakebite is a medical emergency in many parts of the world, particularly in the temperate regions. According to 2007 World Health Organization (WHO) report, there are about 5 million snakebite incidences resulting in 2.5 million envenoming, and 125,000 deaths occur annually. Most affected are the healthy individuals like children and farming populations with resource poor settings and away from health care centers in low-income countries of Africa, Asia and Latin America. In view of this, the WHO has declared snakebite as an ignored health crisis and a tropical disease. Although the death rate has reduced markedly due to anti-venom regiment, several limitations of it offer scope for better understanding of various ignored issues. Currently, snakebite therapeutics facing plethora of scientific, technological and public health challenges, including secondary/long term complications that have not been given importance so far. Because of dearth of knowledge, venom researchers and medical practitioners from affected countries worldwide should join together to accomplish this scenario. In view of this, the present review provides a broader perspective on the possible production and application of highly effective therapeutic master anti-venom, designing master diagnostic kit and also to deal with the inefficacy of anti-venom therapy against local manifestations and secondary complications of snakebite. The review demands thorough understanding of venom pharmacology, inculcating new strategies to handle and to enhance the efficacy of snakebite management and urge the governing systems of affected countries to take steps to curtail accidental debilitation and death rate of healthy individuals due to snakebite.
Assuntos
Terapia Combinada/métodos , Fragmentos Fab das Imunoglobulinas/administração & dosagem , Necrose/tratamento farmacológico , Doenças Negligenciadas/terapia , Cuidados Paliativos/métodos , Mordeduras de Serpentes/terapia , Venenos de Serpentes/efeitos adversos , Adulto , África , Antivenenos/administração & dosagem , Antivenenos/uso terapêutico , Ásia , Criança , Gerenciamento Clínico , Humanos , Hialuronoglucosaminidase/antagonistas & inibidores , Hialuronoglucosaminidase/metabolismo , Fragmentos Fab das Imunoglobulinas/uso terapêutico , Infusões Intravenosas , América Latina , Metaloproteases/antagonistas & inibidores , Metaloproteases/metabolismo , Necrose/patologia , Necrose/prevenção & controle , Doenças Negligenciadas/diagnóstico , Doenças Negligenciadas/mortalidade , Doenças Negligenciadas/patologia , Doenças Negligenciadas/prevenção & controle , Plantas Medicinais , Saúde Pública , Mordeduras de Serpentes/diagnóstico , Mordeduras de Serpentes/mortalidade , Mordeduras de Serpentes/patologia , Mordeduras de Serpentes/prevenção & controle , Venenos de Serpentes/enzimologiaRESUMO
A major myonecrotic zinc containing metalloprotease 'malabarin' with thrombin like activity was purified by the combination of gel permeation and anion exchange chromatography from T. malabaricus snake venom. MALDI-TOF analysis of malabarin indicated a molecular mass of 45.76 kDa and its N-terminal sequence was found to be Ile-Ile-Leu- Pro(Leu)-Ile-Gly-Val-Ile-Leu(Glu)-Thr-Thr. Atomic absorption spectral analysis of malabarin raveled the association of zinc metal ion. Malabarin is not lethal when injected i.p. or i.m. but causes extensive hemorrhage and degradation of muscle tissue within 24 hours. Sections of muscle tissue under light microscope revealed hemorrhage and congestion of blood vessel during initial stage followed by extensive muscle fiber necrosis with elevated levels of serum creatine kinase and lactate dehydrogenase activity. Malabarin also exhibited strong procoagulant action and its procoagulant action is due to thrombin like activity; it hydrolyzes fibrinogen to form fibrin clot. The enzyme preferentially hydrolyzes Aα followed by B subunits of fibrinogen from the N-terminal region and the released products were identified as fibrinopeptide A and fibrinopeptide B by MALDI. The myonecrotic, fibrinogenolytic and subsequent procoagulant activities of malabarin was neutralized by specific metalloprotease inhibitors such as EDTA, EGTA and 1, 10-phenanthroline but not by PMSF a specific serine protease inhibitor. Since there is no antivenom available to neutralize local toxicity caused by T. malabaricus snakebite, EDTA chelation therapy may have more clinical relevance over conventional treatment.
Assuntos
Quelantes/farmacologia , Venenos de Crotalídeos/antagonistas & inibidores , Ácido Edético/farmacologia , Hemorragia/tratamento farmacológico , Metaloproteases/antagonistas & inibidores , Necrose/tratamento farmacológico , Mordeduras de Serpentes , Trimeresurus/fisiologia , Animais , Antivenenos/química , Antivenenos/farmacologia , Coagulação Sanguínea , Quelantes/química , Cromatografia em Gel , Creatina Quinase/análise , Creatina Quinase/metabolismo , Venenos de Crotalídeos/enzimologia , Venenos de Crotalídeos/toxicidade , Ácido Edético/química , Hemorragia/patologia , Hemorragia/prevenção & controle , L-Lactato Desidrogenase/análise , L-Lactato Desidrogenase/metabolismo , Masculino , Metaloproteases/química , Metaloproteases/isolamento & purificação , Metaloproteases/toxicidade , Camundongos , Peso Molecular , Músculos/efeitos dos fármacos , Músculos/patologia , Necrose/patologia , Necrose/prevenção & controle , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Zinco/metabolismoRESUMO
Four compounds (isoquercitrin, myricetin-3-O-glucoside, catechin and gallocatechin) were isolated from lyophilized aqueous extract of Schizolobium parahyba leaves by chromatography on Sephadex LH-20, followed by semipreparative HPLC using a C-18 column, and identified by 1H and 13C NMR. The compounds were then, tested against hemorrhagic and fibrinogenolytic activities of Bothrops crude venoms and isolated metalloproteinases. The inhibitors neutralized the biological and enzymatic activities of Bothrops venoms and toxins isolated from B. jararacussu and B. neuwiedi venoms. The results showed that gallocatechin and myricetin-3-O-glucoside are good inhibitors of hemorrhagic and fibrinogenolytic activities of metalloproteinases, respectively. Gallocatechin also inhibited the myotoxic activity of both B. alternatus venom and BnSP-6 (Lys49 PhospholipaseA2 from B. neuwiedi). Circular dichroism and docking simulation studies were performed in order to investigate the possible interaction between BnSP-6 and gallocatechin. This is the first time these compounds and their anti-ophidian properties are reported for S. parahyba species. Forthcoming studies involving X-ray co-crystallization, will be of great importance for the development of new therapeutic agents for the treatment of ophidian accidents and for the better understanding of the structure/function relationship of venom toxins.
Assuntos
Antivenenos/farmacologia , Bothrops/fisiologia , Venenos de Crotalídeos/antagonistas & inibidores , Fabaceae/química , Flavonoides/farmacologia , Hemorragia/tratamento farmacológico , Metaloproteases/antagonistas & inibidores , Inibidores de Fosfolipase A2 , Mordeduras de Serpentes , Animais , Antivenenos/química , Antivenenos/isolamento & purificação , Cromatografia de Afinidade , Cromatografia Líquida de Alta Pressão , Dicroísmo Circular , Venenos de Crotalídeos/química , Venenos de Crotalídeos/enzimologia , Venenos de Crotalídeos/isolamento & purificação , Venenos de Crotalídeos/toxicidade , Fibrinolíticos/química , Fibrinolíticos/isolamento & purificação , Fibrinolíticos/toxicidade , Flavonoides/química , Flavonoides/isolamento & purificação , Hemorragia/patologia , Hemorragia/prevenção & controle , Espectroscopia de Ressonância Magnética , Masculino , Metaloproteases/química , Metaloproteases/isolamento & purificação , Metaloproteases/toxicidade , Camundongos , Modelos Moleculares , Músculos/efeitos dos fármacos , Músculos/patologia , Fosfolipases A2/química , Fosfolipases A2/isolamento & purificação , Fosfolipases A2/toxicidade , Extratos Vegetais/química , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/farmacologia , Folhas de Planta/químicaRESUMO
Despite a long history on treatment and management of snakebite, as of now, no satisfactory cure exists to treat local toxicity, including anti-venom therapy. Several natural compounds from plants and their synthetic analogs have shown to be protective. In this study 3, 4, 5-tri-hydroxy benzoic acid, the gallic acid (GA) was tested against the local toxicity of Daboia russelli (DR) venom and its purified hemorrhagic complex (HC). GA inhibited in vitro proteolytic activity of both DR venom and HC but, it did not inhibit phospholipase activity of DR venom. GA inhibited hemorrhage, edema forming, dermo- and myonecrotic activities of both HC and DR venom in in vivo experiments. GA was particularly effective against hemorrhagic activity but, GA inhibition had a greater effect on HC when compared to DR venom. The inhibition was likely due to GA induced structural changes in HC as revealed by alterations in fluorescence emission and CD spectral properties. However, the inhibition was not due to chelating property of GA as suggested by UV-visible spectral studies. Inhibition of collagen type IV, laminin and fibronectin degradation essentially provided the biochemical basis for GA which inhibited local effects of HC as well as DR venom. Thus, the study appears highly promising to explore GA and its generics against ruthless local effects and perhaps systemic hemorrhage of DR and other snake bites as well. Further, these agents will possibly find an immense value in the regulation of matrix metalloproteases (MMPs) in processes such as wound healing, inflammation and in the treatment of cancer.
Assuntos
Antivenenos/farmacologia , Daboia/fisiologia , Edema/tratamento farmacológico , Ácido Gálico/farmacologia , Hemorragia/tratamento farmacológico , Necrose/tratamento farmacológico , Mordeduras de Serpentes , Venenos de Víboras/antagonistas & inibidores , Animais , Antivenenos/química , Antivenenos/uso terapêutico , Dicroísmo Circular , Edema/patologia , Edema/prevenção & controle , Eritrócitos/efeitos dos fármacos , Proteínas da Matriz Extracelular/metabolismo , Ácido Gálico/química , Ácido Gálico/uso terapêutico , Hemólise/efeitos dos fármacos , Hemorragia/patologia , Hemorragia/prevenção & controle , Metaloproteases/antagonistas & inibidores , Metaloproteases/metabolismo , Metaloproteases/toxicidade , Camundongos , Músculos/efeitos dos fármacos , Músculos/patologia , Necrose/patologia , Necrose/prevenção & controle , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Proteólise/efeitos dos fármacos , Espectrometria de Fluorescência , Venenos de Víboras/administração & dosagem , Venenos de Víboras/efeitos adversos , Venenos de Víboras/isolamento & purificaçãoRESUMO
This study aims at the identification of novel structural features on the surface of the Zn-dependent metalloprotease lethal factor (LF) from anthrax onto which to design novel and selective inhibitors. We report that by targeting an unexplored region of LF that exhibits ligand-induced conformational changes, we could obtain inhibitors with at least 30-fold LF selectivity compared to two other most related human metalloproteases, MMP-2 and MMP-9. Based on these results, we propose a novel pharmacophore model that, together with the preliminarily identified compounds, should help the design of more potent and selective inhibitors against anthrax.
Assuntos
Toxinas Bacterianas/antagonistas & inibidores , Inibidores Enzimáticos/química , Antraz/tratamento farmacológico , Antígenos de Bactérias/química , Toxinas Bacterianas/química , Cristalografia por Raios X , Avaliação Pré-Clínica de Medicamentos , Humanos , Metaloproteases/antagonistas & inibidores , Metaloproteases/química , Modelos Moleculares , Relação Estrutura-AtividadeRESUMO
Snake venoms are complex toxin mixtures. Viperidae and Crotalidae venoms, which are hemotoxic, are responsible for most of the envenomations around the world. Administration of antivenins aimed at the neutralization of toxins in humans is prone to potential risks. Neutralization of snake venom toxins has been achieved through different approaches: plant extracts have been utilized in etnomedicine. Direct electric current from low voltage showed neutralizing properties against venom phospholipase A2 and metalloproteases. This mini-review summarizes new achievements in venom key component inhibition. A deeper knowledge of alternative ways to inhibit venom toxins may provide supplemental treatments to serum therapy.
Assuntos
Hemorragia/induzido quimicamente , Metaloproteases/antagonistas & inibidores , Inibidores de Fosfolipase A2 , Venenos de Serpentes/antagonistas & inibidores , Animais , Antivenenos/farmacologia , Terapia por Estimulação Elétrica , Humanos , Extratos Vegetais/farmacologia , Mordeduras de Serpentes/terapia , Venenos de Serpentes/toxicidadeRESUMO
Given their medical importance, proteases have been studied by diverse approaches and screened for small molecule protease inhibitors. Here, we present a multiplexed microsphere-based protease assay that uses high-throughput flow cytometry to screen for inhibitors of the light chain protease of botulinum neurotoxin type A (BoNTALC). Our assay uses a full-length substrate and several deletion mutants screened in parallel to identify small molecule inhibitors. The use of multiplex flow cytometry has the advantage of using full-length substrates, which contain already identified distal-binding elements for the BoNTALC, and could lead to a new class of BoNTALC inhibitors. In this study, we have screened 880 off patent drugs and bioavailable compounds to identify ebselen as an in vitro inhibitor of BoNTALC. This discovery demonstrates the validity of our microsphere-based approach and illustrates its potential for high-throughput screening for inhibitors of proteases in general.
Assuntos
Toxinas Botulínicas Tipo A/antagonistas & inibidores , Avaliação Pré-Clínica de Medicamentos/métodos , Citometria de Fluxo/métodos , Ensaios de Triagem em Larga Escala/métodos , Inibidores de Proteases/farmacologia , Antígenos de Bactérias , Azóis/farmacologia , Toxinas Bacterianas/antagonistas & inibidores , Transferência Ressonante de Energia de Fluorescência , Isoindóis , Metaloproteases/antagonistas & inibidores , Microesferas , Compostos Organosselênicos/farmacologiaRESUMO
Snakebite envenomations cause severe local tissue necrosis and the venom metalloproteinases are thought to be the key toxins involved. In this study, the ethanolic extract from seed kernels of Thai mango (Mangifera indica L. cv. 'Fahlun') (Anacardiaceae) and its major phenolic principle (pentagalloylglucopyranose) exhibited potent and dose-dependent inhibitory effects on the caseinolytic and fibrinogenolytic activities of Malayan pit viper and Thai cobra venoms in in vitro tests. molecular docking studies revealed that the binding orientations of the phenolic principles were in the binding pockets of snake venom metalloproteinases (SVMPs). The phenolic principles could form hydrogen bonds with the three histidine residues in the conserved zinc-binding motif and could chelate the Zn(2+) atom of the SVMPs, which could potentially result in inhibition of the venom enzymatic activities and thereby inhibit tissue necrosis.
Assuntos
Antivenenos/metabolismo , Mangifera/química , Metaloproteases/antagonistas & inibidores , Modelos Moleculares , Extratos Vegetais/farmacologia , Sementes/química , Venenos de Serpentes/enzimologia , Animais , Antivenenos/química , Sítios de Ligação , Caseínas/antagonistas & inibidores , Bovinos , Venenos de Crotalídeos/química , Venenos Elapídicos/química , Fibrinogênio/antagonistas & inibidores , Glicoproteínas/química , Ligantes , Extratos Vegetais/química , Conformação Proteica , TailândiaRESUMO
Five novel metalloproteinase protein inhibitors (MPIs) with molecular mass between 5.6 and 8.9 kDa and acid/neutral pI were detected in lupin seeds and exhibited strong inhibitory activities against thermolysin and/or gelatinase B. These novel peptides constitute not only the first MPIs described in plants but also the first plant peptides with inhibitory activity against a matrixin.
Assuntos
Descoberta de Drogas , Lupinus/química , Metaloproteases/antagonistas & inibidores , Peptídeos/farmacologia , Proteínas de Plantas/farmacologia , Inibidores de Proteases/farmacologia , Animais , Bactérias/enzimologia , Biologia Computacional , Bases de Dados de Proteínas , Eletroforese em Gel Bidimensional , Humanos , Peso Molecular , Peptídeos/análise , Peptídeos/química , Extratos Vegetais/análise , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Proteínas de Plantas/análise , Proteínas de Plantas/química , Inibidores de Proteases/análise , Inibidores de Proteases/química , Proteômica , Sementes/química , Espectrometria de Massas em Tandem , Termolisina/antagonistas & inibidores , UltrafiltraçãoRESUMO
We evaluate the effect of a standardized dietary supplementation with omega-3 polyunsaturated fatty acids (n-3 PUFAs) on the level of some markers of vascular remodeling in patients with combined dyslipidemia. Three hundred and thirty-three patients received placebo or n-3 PUFAs for 6 months. We evaluated body mass index, glycemic profile, blood pressure, lipid profile, lipoprotein(a), plasminogen activator inhibitor-1, homocysteine, fibrinogen, high-sensitivity C reactive protein, ADP, MMP-2 and MMP-9, and tissue inhibitors of metalloproteinase-1 and -2. A significant increase of high-density lipoprotein-cholesterol, and a significant decrease of triglycerides were present after 3 and 6 months with n-3 PUFAs intake. A significant plasminogen activator inhibitor-1, fibrinogen and high-sensitivity C reactive protein decrease was obtained after 3 and 6 months and a significant ADP increase was observed after 3 and 6 months of n-3 PUFAs. A significant MMP-2, MMP-9, tissue inhibitors of metalloproteinase-1 and tissue inhibitors of metalloproteinase-2 decrease was obtained after 6 months compared to the baseline value with n-3 PUFAs intake. n-3 PUFAs give a better lipid profile and a better improvement of coagulation, fibrinolytic and inflammatory parameters than placebo. Furthermore, lowers levels of MMP-2, MMP-9 and their tissue inhibitors are obtained with n-3 PUFAs compared to placebo.